These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6370397)

  • 1. Comparative pathogenicity of auxotrophic mutants of Candida albicans.
    Manning M; Snoddy CB; Fromtling RA
    Can J Microbiol; 1984 Jan; 30(1):31-5. PubMed ID: 6370397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal pathology and spleen cell chemiluminescence of mice infected with a wild-type and a low-virulence mutant of Candida albicans.
    Fromtling RA; Abruzzo GK; Edison A; Manning-Zweerink M
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 May; 268(3):405-15. PubMed ID: 3043983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenicity of Candida albicans auxotrophic mutants in experimental infections.
    Kirsch DR; Whitney RR
    Infect Immun; 1991 Sep; 59(9):3297-300. PubMed ID: 1879944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphology, Physiology, and Virulence of Some Mutants of Candida albicans.
    Savage N; Balish E
    Infect Immun; 1971 Jan; 3(1):141-8. PubMed ID: 16557930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pathogenicity of a wild-type strain and respiratory mutants of Candida albicans in mice.
    Aoki S; Ito-Kuwa S; Nakamura Y; Masuhara T
    Zentralbl Bakteriol; 1990 Aug; 273(3):332-43. PubMed ID: 2206203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of oxidative stress tolerance resulted in reduced ability to undergo morphologic transitions and decreased pathogenicity in a t-butylhydroperoxide-tolerant mutant of Candida albicans.
    Fekete A; Emri T; Gyetvai A; Gazdag Z; Pesti M; Varga Z; Balla J; Cserháti C; Emody L; Gergely L; Pócsi I
    FEMS Yeast Res; 2007 Sep; 7(6):834-47. PubMed ID: 17498215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PMT family of Candida albicans: five protein mannosyltransferase isoforms affect growth, morphogenesis and antifungal resistance.
    Prill SK; Klinkert B; Timpel C; Gale CA; Schröppel K; Ernst JF
    Mol Microbiol; 2005 Jan; 55(2):546-60. PubMed ID: 15659169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans.
    Angiolella L; Stringaro AR; De Bernardis F; Posteraro B; Bonito M; Toccacieli L; Torosantucci A; Colone M; Sanguinetti M; Cassone A; Palamara AT
    Antimicrob Agents Chemother; 2008 Mar; 52(3):927-36. PubMed ID: 18180350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenicity of 5-fluorocytosine resistant strains of Candida albicans.
    Fasoli MO; Kerridge D; Ryley JF
    J Med Vet Mycol; 1990; 28(1):27-34. PubMed ID: 2194016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida albicans growth studies: a hypothesis for the pathogenesis of Candida infections in burns.
    Neely AN; Orloff MM; Holder IA
    J Burn Care Rehabil; 1992; 13(3):323-9. PubMed ID: 1377693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans.
    Navarathna DH; Hornby JM; Krishnan N; Parkhurst A; Duhamel GE; Nickerson KW
    Infect Immun; 2007 Apr; 75(4):1609-18. PubMed ID: 17283095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida albicans antifungal-resistant strains: studies on adherence and other pathogenicity related characteristics.
    Ghannoum MA
    Mycoses; 1992; 35(5-6):131-9. PubMed ID: 1474984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Candida albicans Ddr48 protein is essential for filamentation, stress response, and confers partial antifungal drug resistance.
    Dib L; Hayek P; Sadek H; Beyrouthy B; Khalaf RA
    Med Sci Monit; 2008 Jun; 14(6):BR113-121. PubMed ID: 18509269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation of virulence, pathogenicity, and itraconazole resistance with SAP activity in Candida albicans strains.
    Feng W; Yang J; Pan Y; Xi Z; Qiao Z; Ma Y
    Can J Microbiol; 2016 Feb; 62(2):173-8. PubMed ID: 26751517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aculeacin A resistant mutants of Candida albicans.
    Mehta RJ; Nash CH; Grappel SF; Actor P
    J Antibiot (Tokyo); 1982 Jun; 35(6):707-11. PubMed ID: 6749782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans.
    Sullivan DJ; Moran GP; Pinjon E; Al-Mosaid A; Stokes C; Vaughan C; Coleman DC
    FEMS Yeast Res; 2004 Jan; 4(4-5):369-76. PubMed ID: 14734017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avirulence of Candida albicans auxotrophic mutants in a rat model of oropharyngeal candidiasis.
    Cole MF; Bowen WH; Zhao XJ; Cihlar RL
    FEMS Microbiol Lett; 1995 Feb; 126(2):177-80. PubMed ID: 7705609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The secreted aspartate proteinase of Candida albicans: physiology of secretion and virulence of a proteinase-deficient mutant.
    Ross IK; De Bernardis F; Emerson GW; Cassone A; Sullivan PA
    J Gen Microbiol; 1990 Apr; 136(4):687-94. PubMed ID: 2204678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infections.
    Shepherd MG
    Infect Immun; 1985 Nov; 50(2):541-4. PubMed ID: 3902649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Hwp2, a Candida albicans putative GPI-anchored cell wall protein necessary for invasive growth.
    Hayek P; Dib L; Yazbeck P; Beyrouthy B; Khalaf RA
    Microbiol Res; 2010 Mar; 165(3):250-8. PubMed ID: 19616419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.